488 related articles for article (PubMed ID: 33926590)
1. Circulating bile acids as a link between the gut microbiota and cardiovascular health: impact of prebiotics, probiotics and polyphenol-rich foods.
Pushpass RG; Alzoufairi S; Jackson KG; Lovegrove JA
Nutr Res Rev; 2022 Dec; 35(2):161-180. PubMed ID: 33926590
[TBL] [Abstract][Full Text] [Related]
2. 'The way to a man's heart is through his gut microbiota'--dietary pro- and prebiotics for the management of cardiovascular risk.
Tuohy KM; Fava F; Viola R
Proc Nutr Soc; 2014 May; 73(2):172-85. PubMed ID: 24495527
[TBL] [Abstract][Full Text] [Related]
3. Chronic consumption of probiotics, oats, and apples has differential effects on postprandial bile acid profile and cardiometabolic disease risk markers compared with an isocaloric control (cornflakes): a randomized trial.
Pushpass RG; Alzoufairi S; Mancini A; Quilter K; Fava F; Delaiti S; Vrhovsek U; Christensen C; Joyce SA; Tuohy KM; Jackson KG; Lovegrove JA
Am J Clin Nutr; 2023 Feb; 117(2):252-265. PubMed ID: 36811563
[TBL] [Abstract][Full Text] [Related]
4. Effectiveness of probiotics, prebiotics, and prebiotic-like components in common functional foods.
Peng M; Tabashsum Z; Anderson M; Truong A; Houser AK; Padilla J; Akmel A; Bhatti J; Rahaman SO; Biswas D
Compr Rev Food Sci Food Saf; 2020 Jul; 19(4):1908-1933. PubMed ID: 33337097
[TBL] [Abstract][Full Text] [Related]
5. A novel polyphenolic prebiotic and probiotic formulation have synergistic effects on the gut microbiota influencing Drosophila melanogaster physiology.
Westfall S; Lomis N; Prakash S
Artif Cells Nanomed Biotechnol; 2018; 46(sup2):441-455. PubMed ID: 29644870
[TBL] [Abstract][Full Text] [Related]
6. Functional food addressing heart health: do we have to target the gut microbiota?
Ryan PM; Ross RP; Fitzgerald GF; Caplice NM; Stanton C
Curr Opin Clin Nutr Metab Care; 2015 Nov; 18(6):566-71. PubMed ID: 26406391
[TBL] [Abstract][Full Text] [Related]
7. Cardiovascular Diseases of Developmental Origins: Preventive Aspects of Gut Microbiota-Targeted Therapy.
Hsu CN; Hou CY; Hsu WH; Tain YL
Nutrients; 2021 Jul; 13(7):. PubMed ID: 34371800
[TBL] [Abstract][Full Text] [Related]
8. Relationship between gut microbiota and colorectal cancer: Probiotics as a potential strategy for prevention.
Lee SY; Lee DY; Kang JH; Kim JH; Jeong JW; Kim HW; Oh DH; Yoon SH; Hur SJ
Food Res Int; 2022 Jun; 156():111327. PubMed ID: 35651078
[TBL] [Abstract][Full Text] [Related]
9. Targeting the Gut Microbiota for Remediating Obesity and Related Metabolic Disorders.
Wang B; Wang L; Wang H; Dai H; Lu X; Lee YK; Gu Z; Zhao J; Zhang H; Chen W; Wang G
J Nutr; 2021 Jul; 151(7):1703-1716. PubMed ID: 33982127
[TBL] [Abstract][Full Text] [Related]
10. Small molecule inhibition of gut microbial choline trimethylamine lyase activity alters host cholesterol and bile acid metabolism.
Pathak P; Helsley RN; Brown AL; Buffa JA; Choucair I; Nemet I; Gogonea CB; Gogonea V; Wang Z; Garcia-Garcia JC; Cai L; Temel R; Sangwan N; Hazen SL; Brown JM
Am J Physiol Heart Circ Physiol; 2020 Jun; 318(6):H1474-H1486. PubMed ID: 32330092
[TBL] [Abstract][Full Text] [Related]
11. Emerging Roles of Gut Microbial Modulation of Bile Acid Composition in the Etiology of Cardiovascular Diseases.
Yntema T; Koonen DPY; Kuipers F
Nutrients; 2023 Apr; 15(8):. PubMed ID: 37111068
[TBL] [Abstract][Full Text] [Related]
12. The impact of probiotics, prebiotics, and synbiotics on the biochemical, clinical, and immunological markers, as well as on the gut microbiota of obese hosts.
da Silva TF; Casarotti SN; de Oliveira GLV; Penna ALB
Crit Rev Food Sci Nutr; 2021; 61(2):337-355. PubMed ID: 32156153
[TBL] [Abstract][Full Text] [Related]
13. GUT MICROBIOTA, PREBIOTICS, PROBIOTICS, AND SYNBIOTICS IN MANAGEMENT OF OBESITY AND PREDIABETES: REVIEW OF RANDOMIZED CONTROLLED TRIALS.
Barengolts E
Endocr Pract; 2016 Oct; 22(10):1224-1234. PubMed ID: 27409822
[TBL] [Abstract][Full Text] [Related]
14. Nutrition and Gastrointestinal Microbiota, Microbial-Derived Secondary Bile Acids, and Cardiovascular Disease.
Rodríguez-Morató J; Matthan NR
Curr Atheroscler Rep; 2020 Jul; 22(9):47. PubMed ID: 32681421
[TBL] [Abstract][Full Text] [Related]
15. The Role of Gut Microbiota on Cholesterol Metabolism in Atherosclerosis.
Vourakis M; Mayer G; Rousseau G
Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360839
[TBL] [Abstract][Full Text] [Related]
16. Regulation of gut microbiota-bile acids axis by probiotics in inflammatory bowel disease.
Li L; Liu T; Gu Y; Wang X; Xie R; Sun Y; Wang B; Cao H
Front Immunol; 2022; 13():974305. PubMed ID: 36211363
[TBL] [Abstract][Full Text] [Related]
17. Therapeutic modulation methods of gut microbiota and gut-liver axis.
Beyaz Coşkun A; Sağdiçoğlu Celep AG
Crit Rev Food Sci Nutr; 2022; 62(23):6505-6515. PubMed ID: 33749411
[TBL] [Abstract][Full Text] [Related]
18. Resveratrol Attenuates Trimethylamine-N-Oxide (TMAO)-Induced Atherosclerosis by Regulating TMAO Synthesis and Bile Acid Metabolism via Remodeling of the Gut Microbiota.
Chen ML; Yi L; Zhang Y; Zhou X; Ran L; Yang J; Zhu JD; Zhang QY; Mi MT
mBio; 2016 Apr; 7(2):e02210-15. PubMed ID: 27048804
[TBL] [Abstract][Full Text] [Related]
19. Short-chain fatty acids as a link between diet and cardiometabolic risk: a narrative review.
Birkeland E; Gharagozlian S; Valeur J; Aas AM
Lipids Health Dis; 2023 Mar; 22(1):40. PubMed ID: 36915164
[TBL] [Abstract][Full Text] [Related]
20. Bile Acid-Gut Microbiota Axis in Inflammatory Bowel Disease: From Bench to Bedside.
Yang M; Gu Y; Li L; Liu T; Song X; Sun Y; Cao X; Wang B; Jiang K; Cao H
Nutrients; 2021 Sep; 13(9):. PubMed ID: 34579027
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
